|
|
Home > Healthcare > Biotechnology > General Biotech
Transfection Life Science Dashboard™ Series 2
|
|
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard Series Two was developed from responses to a 24-question survey completed by over 427 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the transfection market as a whole as well as for the following sub-segments:
- Chemically-mediated transfection (i.e. calcium phosphate)
- Lipid-mediated transfection
- Instrument-mediated transfection (i.e. electroporator, Nucleofector®)
- Virus-mediated transfection (Note: for the purposes of this report, virus-mediated transfection refers to the delivery of nucleic acid material into mammalian cells or cell lines using virus and/or viral-based gene delivery systems).
The genomics revolution has set the table for the study of gene expression & regulation as well as protein structure and function. The technique of transfection
Please note, the online download version is a global site license version of the report.
|
Similar Products
• Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
Published Nov 2009 by Amadee & Company
• Biotechnology (Pharmaceuticals) Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Opportunities in Human Embryonic Stem Cell (hESC) Products
Published Nov 2009 by BioInformant Worldwide, L.L.C.
• Global Stem Cell and Advanced Technologies Market
Published Nov 2009 by MarketsandMarkets
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Acorda Therapeutics, Inc. - SWOT Analysis
Published Oct 2009 by Datamonitor
• Future of Green Biotechnology in China
Published Oct 2009 by CCM International Limited
• Scientific Research in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
|
|
|
|
0 items
